Congenital Disorders Codexery

Achondroplasia

Genetic disorder causing disproportionate dwarfism due to FGFR3 mutation.

Achondroplasia

Sydney S. Gellis and Murray Feingold · Public domain

Achondroplasia is a genetic condition primarily marked by dwarfism, making it the most common form, occurring in about 1 in 15,000 to 1 in 25,000 live births. Individuals have short arms and legs with a torso of typical length; average adult height is 131 centimeters (4 ft 4 in) for males and 123 centimeters (4 ft) for females. Other features may include a large head with a prominent forehead, underdevelopment of the midface, and complications such as sleep apnea or recurrent ear infections.

The condition stems from a mutation in the FGFR3 gene on chromosome 4, which makes the protein overactive and disrupts bone growth within cartilage. It follows an autosomal dominant inheritance pattern, meaning only one altered gene copy is needed. About 80% of cases arise from new, spontaneous mutations, often originating during sperm production, with the risk increasing with the father's age. The remaining cases are inherited from an affected parent. When both parents have achondroplasia, children who inherit two mutated genes (a 25% chance) usually die before birth or in early infancy due to breathing difficulties. Diagnosis is typically based on physical features but can be confirmed with genetic testing. Related conditions caused by FGFR3 mutations include hypochondroplasia and SADDAN (severe achondroplasia with developmental delay and acanthosis nigricans), a rare disorder with severe short-limb skeletal dysplasia.

Treatments include vosoritide, a C-natriuretic peptide analog approved to improve growth velocity in children based on Phase 3 trials, though its long-term effects are unknown. Growth hormone therapy may also be used. Managing complications like obesity, hydrocephalus, obstructive sleep apnea, middle ear infections, or spinal stenosis may require additional care. Support groups such as Little People of America exist, along with nonprofit physician organizations that provide information on treatment and patient resources.

Quick Facts

Field
Medical genetics
Symptoms
Short arms and legs, enlarged head, prominent forehead
Complications
Ear infections, hyperlordosis, back pain, spinal stenosis, hydrocephalus
Onset
Congenital
Duration
Lifelong
Causes
Genetic (autosomal dominant mutation in the FGFR3 gene)
Risks
Paternal age
Diagnosis
Based on symptoms, genetic testing if uncertain
Differential
Hypochondroplasia, thanatophoric dysplasia, cartilage-hair hypoplasia, pseudoachondroplasia
Treatment
Support groups, growth hormone therapy, treatment of complications
Frequency
1 in 27,500 people

Facts from the source article.

Lore & Background

Achondroplasia is characterized by short arms and legs with a normal-length torso, an enlarged head with prominent forehead, and underdevelopment of the midface. Complications can include sleep apnea, recurrent ear infections, and hydrocephalus. In children, delayed walking and motor skills are common, along with bowed legs, scoliosis, and breathing problems. Adults often face obesity, sleep apnea, and nerve compression. Pregnancy in women with achondroplasia is considered higher risk, and delivery is typically by C-section.

Reader's Guide

Achondroplasia is significant as the most common form of dwarfism, affecting bone growth through a gain-of-function mutation in FGFR3. The disorder is autosomal dominant, with most cases arising from new mutations linked to paternal age. Treatments include vosoritide, a C-natriuretic peptide analog approved to improve growth velocity in children, though long-term effects are unknown. Growth hormone therapy may also be used. Support groups like Little People of America provide resources. The condition is generally diagnosed based on clinical features and confirmed by genetic testing. Intelligence and life span are usually near normal, though craniocervical junction compression increases infant mortality risk.

Did You Know?

Physical Presentation & Daily Life

The most immediately visible hallmark of achondroplasia is a pattern of disproportionate short stature in which the torso retains a roughly normal length while the arms and legs are markedly shortened, a pattern clinicians call rhizomelic shortening. Adult males typically reach around 131 centimetres and females around 123 centimetres. The hands and feet carry a distinctive trident appearance: fingers and toes are short and stubby, with a noticeable gap separating the middle and ring digits, a feature often first spotted on fetal ultrasound. The skull tends to be enlarged with a prominent, sloping forehead, while the midface is underdeveloped, producing a flattened nasal bridge. Postural challenges are common, including abnormal spinal curvatures such as kyphosis or lordosis, and leg deformities like bowlegs or knock-knees. Despite these skeletal differences, intelligence and overall life expectancy generally fall within the normal range, though craniocervical junction compression does elevate the risk of death in infancy.

Genetic Mechanism & Inheritance

Achondroplasia traces back to a single genetic change: a gain-of-function mutation in the FGFR3 gene on chromosome 4. Under normal conditions, the FGFR3 protein acts as a brake on endochondral bone growth, the process by which cartilage is gradually replaced by mature bone. When the mutation renders the receptor constitutively active, that brake is effectively stuck, and cartilage fails to convert fully into bone, producing the characteristically shortened limbs. Because the condition follows an autosomal dominant pattern, a single altered copy is enough to cause the disorder, while inheriting two copies is invariably lethal before or shortly after birth due to respiratory failure from an underdeveloped ribcage. Roughly 80 percent of new cases arise spontaneously, most often as a de novo change during sperm formation, and the likelihood of such a spontaneous mutation rises with the father's age. The remaining cases are passed from an affected parent, with a 50 percent transmission risk per pregnancy. Related FGFR3 mutations give rise to hypochondroplasia and the exceedingly rare SADDAN syndrome, which adds severe immunodeficiency, brain, and skin abnormalities to the skeletal picture.

Medical Complications Across the Lifespan

Complications of achondroplasia shift in character as a person grows. In early childhood, reduced muscle tone frequently delays the acquisition of walking and other motor milestones. Bowed legs, scoliosis, lordosis, arthritis, and limited joint flexibility are common, and crowded teeth add another layer of dental concern. A particularly serious pediatric risk is hydrocephalus: the narrowing of the spinal canal obstructs the normal circulation of cerebrospinal fluid, leading to fluid accumulation that manifests as an enlarged head, persistent vomiting, lethargy, headaches, and irritability. Treatment usually involves shunt surgery, though an endoscopic third ventriculostomy is an alternative. Eustachian tube blockages predispose children to recurrent middle-ear infections, and both central and obstructive sleep apnea can appear at any age. In adulthood, the picture often centers on obesity, worsening sleep apnea, and numbness or tingling in the legs caused by spinal stenosis compressing nerves. Psychosocial strain linked to short stature is also documented. For women, pregnancy carries elevated risk, and delivery is generally performed by caesarean section to prevent complications that could arise during a natural birth.

Treatment, Management & Community Support

Management of achondroplasia is multifaceted, addressing both growth and the constellation of secondary complications. The small-molecule drug vosoritide, a C-natriuretic peptide analog, received approval to improve growth velocity in affected children based on Phase 3 clinical-trial results, although its long-term safety profile remains to be fully established. Growth-hormone therapy is another option some clinicians consider. Structural and functional problems are handled through a toolkit that includes corrective surgery, braces, and ongoing physical therapy, while separate interventions target obesity, hydrocephalus, obstructive sleep apnea, recurrent middle-ear infections, and spinal stenosis. Beyond the clinic, a network of support and information resources has grown. Little People of America (LPA) serves as a prominent peer-support organization for individuals and families living with the condition. Nonprofit physician groups work to disseminate evidence-based treatment guidance and develop patient-facing educational materials, helping to bridge the gap between specialist knowledge and day-to-day self-management.

Gallery

Frequently Asked Questions

What is Achondroplasia?

Achondroplasia is a genetic condition that causes disproportionate short stature, making it the most frequently seen form of dwarfism. It results from a mutation in the FGFR3 gene on chromosome 4, which causes the associated protein to become overactive and disrupts normal bone growth.

What does Achondroplasia look like physically?

People with the condition typically have noticeably shorter arms and legs while the torso remains at a typical length, with average adult heights around 131 cm for males and 123 cm for females. Other recognizable traits include a larger-than-average head, a prominent forehead, and a somewhat underdeveloped midface.

How common is Achondroplasia?

It occurs in roughly 1 in 15,000 to 1 in 25,000 live births, making it the most prevalent form of dwarfism. Most cases arise from a new (de novo) mutation in the FGFR3 gene rather than being inherited from a parent.

What health complications are associated with Achondroplasia?

Because of the altered skeletal structure, individuals may experience sleep apnea and recurrent ear infections. These secondary issues stem from the underdevelopment of the midface and the narrowing of certain anatomical passages.

Is Achondroplasia inherited or random?

It is caused by a specific mutation in the FGFR3 gene on chromosome 4, and it can be passed down through families in an autosomal dominant pattern. However, the majority of cases are new mutations that occur spontaneously, meaning neither parent carries the change.

More in Congenital disorders 1-24

Spotted an error? Know more?

Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced

Comments

Loading…
Open in the interactive codex →